The global autologous fat grafting market is expected to grow in the forecast period due to the increasing demand for minimally invasive and non-invasive procedures and the decreased disparity between men and women for aesthetic functions. The market is also influenced by the growing aesthetic consciousness and beauty standards and growing technological advancement. However, the global autologous fat grafting market is expected to be hampered by the high cost of procedures, increased risks associated with the procedures, and product recall.
The customized treatment plans and integration with other aesthetic procedures, beliefs, and trends of autologous fat grafting in young adults the focus on inclusivity and diversity, and the expansion of product lines are expected to act as opportunities for market growth. However, low-term efficacy and sustainability and longer recovery time of the procedure are expected to challenge market growth.
The demand for the autologous fat grafting market has increased in both developed and developing countries, and the reason behind this is its effectiveness and availability. Thus, many market players offer autologous fat grafting products with innovations that pave the way for the growth of the global autologous fat grafting market.
In 2020, according to the American Society for Aesthetic Plastic Surgery (ASAPS), there is approximately 15.6 thousand cosmetic surgical and minimally invasive procedures were performed.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-autologous-fat-grafting-market
Data Bridge Market Research analyzes that the Global Autologous Fat Grafting Market is expected to grow at a CAGR of 9.8% in the forecast period of 2023 to 2030 and is expected to reach USD 2,498,109.12 thousand by 2030. In 2023, the product type segment is expected to dominate the market due to growing technological advancements.
Key Findings of the Study
Growing Aesthetic Consciousness and Beauty Standards
People in both developed and developing countries are becoming more conscious of their appearance. With the increasing standard of living and the growing importance of physical appearance in Western culture, there is a rise in demand for aesthetic surgeries every year.
The awareness towards aesthetic procedures has increased the demand and improved the purchasing power of people, due to which increasing aesthetic consciousness and awareness is expected to boost the demand of the market.
Beauty standards are a set of values applied to the appearance of both men and women to be regarded as beautiful and handsome to rightly fit in the community. Setting beauty ethics is one of the major reasons that forcefully made people change their lifestyles in this ever-changing world hence is expected to drive market growth.
There are numerous reasons for increasing consciousness and awareness towards the appearance of people it includes constant bombardment with advertisements and information on new devices, and improving lifestyle which has boomed in the industry leading to increased awareness of people about their appearance.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customization from 2015 to 2020)
|
|
Quantitative Units
|
Revenue in USD Thousand, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Integrated Fat Transfer Systems, Aspiration and Harvesting Systems, Liposuction Systems, Fat Processing Systems, De-epithelialization Devices, and Accessories), Application (Breast Augmentation, Buttock Augmentation, Facial Fat Grafting, Hand Rejuvenation, and Others), Gender (Male and Female), Age Group (20-40, 41-50, and Above 50), End User (Hospitals, On-Site Clinics, Plastic Surgery Centers, and Others) Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Poland, Sweden, Belgium, Denmark, Finland, Norway, and Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, New Zealand, Taiwan, Vietnam, and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Qatar, Oman, Bahrain, Kuwait, and Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
AbbVie Inc. (U.S.), Alma Lasers (Israel), Tulip Aesthetics (U.S.), Bimini Health Tech (U.S.), Aspire Medical Innovation (Germany), Sterimedix Limited (England), Genesis Biosystems (U.S.), MTF Biologics (U.S.), MicroAire Surgical Instruments, LLC (U.S.), Medicon eG, Human Med AG (Germany), Tulip Aesthetics (U.S.), Lipogems International S.p.A. (Italy), HK Surgical Inc. (U.S.), MÖLLER Medical GmbH (Germany), Grey Medical (Pakistan), Genesis Biosystems (U.S.), Black & Black Surgical(U.S.), and CYNOSURE (U.S.) Solta Medical (U.S.) Medicon eG (Germany), and Mentor World wide LLC (U.S.), among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The global autologous fat grafting market is categorized into six notable segments based on product type, application, gender, age group, end user, and distribution channel.
- On the basis of product type, the market is segmented into liposuction systems, aspiration and harvesting systems, fat processing systems, integrated fat transfer systems, de-epithelialization devices, and accessories.
In 2023, the liposuction systems segment is expected to dominate the global autologous fat grafting market.
In 2023, the liposuction systems segment is expected to dominate the market with 39.91% market share due to increasing demand for aesthetic enhancement procedures.
- On the basis of application, the market is segmented into breast augmentation, buttock augmentation, facial fat grafting, hand rejuvenation, and others
In 2023, the breast augmentation segment is expected to dominate the global autologous fat grafting market.
In 2023, the breast augmentation segment is expected to dominate the market with 44.54% market share due to advancements in minimally invasive techniques and technologies.
- On the basis of gender, the market is segmented into male and female. In 2023, the female segment is expected to dominate the market with 53.47% market share.
- On the basis of age group, the market is segmented into 41-50, 20-40, and above 50. In 2023, the 41-50 segment is expected to dominate the market with a 51.26% market share.
- On the basis of end user, the market is segmented into hospitals, plastic surgery centers, on-site clinics, and others. In 2023, the hospital segment is expected to dominate the market with 41.53% market share.
- On the basis of distribution channel, the market is segmented into direct tender and retail sales. In 2023, the direct tender segment is expected to dominate the market with 58.42% market share.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in global autologous fat grafting market are AbbVie Inc. (U.S.), Alma Lasers (Israel), Tulip Aesthetics (U.S.), Bimini Health Tech (U.S.), Aspire Medical Innovation (Germany), Sterimedix Limited (England), Genesis Biosystems (U.S.), MTF Biologics (U.S.), MicroAire Surgical Instruments, LLC (U.S.), Medicon eG, Human Med AG (Germany), Tulip Aesthetics (U.S.), Lipogems International S.p.A. (Italy), HK Surgical Inc. (U.S.), MÖLLER Medical GmbH (Germany), Grey Medical (Pakistan), Genesis Biosystems (U.S.), Black & Black Surgical(U.S.), and CYNOSURE (U.S.) Solta Medical (U.S.) Medicon eG (Germany), and Mentor World wide LLC (U.S.), among others.
Market Developments
- In August 2023 Bimini Health Tech announced that it had acquired substantially all of the assets of Ideal Implant, Inc., including intellectual property, regulatory approvals, product inventory, and certain manufacturing capacity. This helps the organization develop more revenue.
- In April 2022, Bimini Health Tech (“Bimini” or the “Company”), a diversified global medical aesthetics and regenerative therapy company, announced today that it has received approval from Canada’s Medical Devices Directorate to market the Company’s Dermapose family of microsizing syringe products, including the Dermapose Refresh Microsizing Syringe and the Autopose Restore Microsizing Syringe in Canada. This helps the organization develop more revenue.
- In December 2021, Allergan (a subsidiary of AbbVie Inc.) announced that the company had completed its acquisition with Soliton, Inc. This helped the company expand its aesthetic product portfolio in the market.
- In April 2021, Alma Lasers launched the new Alma PrimeX platform during a global LIVE launch event streamed from its headquarters studio. The best product in its class, Alma PrimeX offers unmatched results in circumference reduction and skin tightening. This aided the business in expanding its product offering.
Regional Analysis
Geographically, the countries covered in the global autologous fat grafting market report U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Poland, Sweden, Belgium, Denmark, Finland, Norway, and Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, New Zealand, Taiwan, Vietnam, and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Qatar, Oman, Bahrain, Kuwait, and Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the global autologous fat grafting market
North America is expected to dominate the market owing to the higher level of investments by various manufacturers and increasing technological advancements in the region. North America will continue to dominate the market in terms of market share and market revenue.
North America is estimated to be the fastest-growing region in the market in the forecast period 2023 - 2030
North America is estimated to be the fastest-growing region in the market in the forecast period of 2023-2030. This is due to the growing adoption of advanced technology and the launch of new products in this region.
For more detailed information about the global autologous fat grafting market report, click here – https://www.databridgemarketresearch.com/reports/global-autologous-fat-grafting-market
